Assignee
CURELAB ONCOLOGY INC
US·2 granted patents·4 pending applications·4 citations·filing 2016–2024
Top patents by PatentIndex Score
6 records- 0182US10716837B2Methods and compositions relating to P62 for the treatment and prophylaxis of cancerCURELAB ONCOLOGY INC·Filed 2016·Granted Jul 21, 2020·3 cites·18 claims
- 0269US11098098B2Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseasesCURELAB ONCOLOGY INC·Filed 2018·Granted Aug 24, 2021·1 cites·6 claims
- 0358US2022009985A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0457US2020338176A1Methods and compositions relating to p62 for the treatment and prophylaxis of cancerCURELAB ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0556US2025332186A1Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated DiseasesCURELAB ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0647US2021220437A1Compositions and Methods Relating to p62 for the Treatment and Prophylaxis of Age-Related Macular DegenerationCURELAB ONCOLOGY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CURELAB ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →